CUPR earnings: real EPS beat/miss history, P/E -2.31. Updated 2026-07-23.
Cuprina Holdings (Cayman) (CUPR) Research Hub
Cuprina Holdings (Cayman) (CUPR) trades on NASDAQ, SG in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 3.15 USD (+8.25%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.31, market cap 0.01B. This hub links to the full technical, earnings and options research available for CUPR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, SG |
| Last close | 3.15 USD (+8.25%) |
| 52-week range | 2.5 USD – 14.8 USD |
| Trend regime | Range |
| 14-day RSI | 44.8 (Bearish) |
| Trailing P/E | -2.31 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
Available research for CUPR
Covered Call on CUPR: how it works, illustrative setup around the real 3.15 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CUPR: how it works, illustrative setup around the real 3.15 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CUPR: how it works, illustrative setup around the real 3.15 USD price, max profit/loss, breakeven and when to use it. Educational.
CUPR technical analysis: range, last 3.15 USD, RSI 44.8, 52w range 2.5 USD–14.8 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CUPR in?
Cuprina Holdings (Cayman) (CUPR) is classified under Healthcare (Biotechnology), listed on NASDAQ, SG.
Is CUPR in an uptrend or downtrend?
As of 2026-09-11, CUPR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CUPR's trailing P/E ratio?
CUPR's trailing P/E is -2.31, with a market cap of 0.01B. See the earnings research page for full valuation detail.